Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.

Tsolenyanu E, Djadou KE, Fiawoo M, Akolly DAE, Mwenda JM, Leshem E, Tate JE, Aliabadi N, Koudema W, Guedenon KM, Godonou M, Dagnra A, Gbadoe AD, Boko A, Landoh D, Atakouma Y, Parashar UD.

Vaccine. 2018 Jan 31. pii: S0264-410X(18)30118-X. doi: 10.1016/j.vaccine.2018.01.058. [Epub ahead of print]

PMID:
29397224
2.

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.

Ngabonziza JCS, Diallo AB, Tagliani E, Diarra B, Kadanga AE, Togo ACG, Thiam A, de Rijk WB, Alagna R, Houeto S, Ba F, Dagnra AY, Ivan E, Affolabi D, Schwoebel V, Trebucq A, de Jong BC, Rigouts L, Daneau G; “Union short MDR-TB regimen study group”.

PLoS One. 2017 Oct 31;12(10):e0187211. doi: 10.1371/journal.pone.0187211. eCollection 2017.

3.

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance.

Gehre F, Otu J, Kendall L, Forson A, Kwara A, Kudzawu S, Kehinde AO, Adebiyi O, Salako K, Baldeh I, Jallow A, Jallow M, Dagnra A, Dissé K, Kadanga EA, Idigbe EO, Onubogu C, Onyejepu N, Gaye-Diallo A, Ba-Diallo A, Rabna P, Mane M, Sanogo M, Diarra B, Dezemon Z, Sanou A, Senghore M, Kwambana-Adams BA, Demba E, Faal-Jawara T, Kumar S, Tientcheu LD, Jallow A, Ceesay S, Adetifa I, Jaye A, Pallen MJ, D'Alessandro U, Kampmann B, Adegbola RA, Mboup S, Corrah T, de Jong BC, Antonio M.

BMC Med. 2016 Nov 3;14(1):160.

4.

Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lomé, Togo: Prevalence and molecular consequences.

Patassi A, Benaboud S, Landoh DE, Salou M, Dagnra AC, Saka B, Krivine A, Meritet JF, Pitché P, Salmon-Ceron D.

S Afr Med J. 2016 May 10;106(6). doi: 10.7196/SAMJ.2016.v106i6.10312.

PMID:
27245734
5.

Genetic diversity and transmission networks of HIV-1 strains among men having sex with men (MSM) in Lomé, Togo.

Konou AA, Vidal N, Salou M, Anato S, Singo-Tokofaï A, Ekouevi DK, Pitché P, Prince-David M, Delaporte E, Peeters M, Dagnra AY.

Infect Genet Evol. 2016 Dec;46:279-285. doi: 10.1016/j.meegid.2016.05.030. Epub 2016 May 25.

PMID:
27235597
6.

High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in Togo.

Salou M, Butel C, Konou AA, Ekouevi DK, Vidal N, Dossim S, Lawson-Evi K, Nyasenu YT, Singo-Tokofaï A, d'Almeida S, Tchama R, Delaporte E, Prince-David M, Peeters M, Dagnra AY.

Pediatr Infect Dis J. 2016 Aug;35(8):879-85. doi: 10.1097/INF.0000000000001203.

PMID:
27167115
7.

High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo.

Salou M, Dagnra AY, Butel C, Vidal N, Serrano L, Takassi E, Konou AA, Houndenou S, Dapam N, Singo-Tokofaï A, Pitche P, Atakouma Y, Prince-David M, Delaporte E, Peeters M.

J Int AIDS Soc. 2016 Apr 27;19(1):20683. doi: 10.7448/IAS.19.1.20683. eCollection 2016.

8.

Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo.

Tsolenyanu E, Mwenda JM, Dagnra A, Leshem E, Godonou M, Nassoury I, Landoh D, Tate JE, Atakouma Y, Parashar UD.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S196-9. doi: 10.1093/cid/civ1182.

PMID:
27059356
9.

Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo.

Konou AA, Salou M, Vidal N, Kodah P, Kombate D, Kpanla P, Nabroulaba T, Nyametso D, Singo-Tokofaï A, Pitche P, Delaporte E, Prince-David M, Peeters M, Dagnra AY.

AIDS Res Ther. 2015 Nov 27;12:38. doi: 10.1186/s12981-015-0082-7. eCollection 2015.

10.

Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo.

Konou AA, Dagnra AY, Vidal N, Salou M, Adam Z, Singo-Tokofai A, Delaporte E, Prince-David M, Peeters M.

AIDS. 2015 Nov 28;29(18):2527-30. doi: 10.1097/QAD.0000000000000906.

PMID:
26558549
11.

Prevalence of multidrug-resistant tuberculosis cases among HIV-positive and HIV-negative patients eligible for retreatment regimen in Togo using GeneXpert MTB/RIF.

Dagnra AY, Mlaga KD, Adjoh K, Kadanga E, Disse K, Adekambi T.

New Microbes New Infect. 2015 Sep 10;8:24-27. doi: 10.1016/j.nmni.2015.09.001. eCollection 2015 Nov.

12.

Evaluation of 9 rapid diagnostic tests for screening HIV infection, in Lomé, Togo.

Dagnra AY, Dossim S, Salou M, Nyasenu T, Ali-Edje K, Ouro-Médeli A, Doufan M, Ehlan A, Prince-David M.

Med Mal Infect. 2014 Dec;44(11-12):525-9. doi: 10.1016/j.medmal.2014.10.007. Epub 2014 Nov 7.

PMID:
25391806
13.

Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.

Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LX, Chaix ML, Delaporte E, Ayouba A, Peeters M; ANRS 12235 Study Group.

J Clin Microbiol. 2014 Feb;52(2):578-86. doi: 10.1128/JCM.02860-13. Epub 2013 Dec 11.

14.

[HIV seroprevalence among drug users in Togo].

Ekouevi DK, Coffie PA, Salou M, Kariyiare BG, Dagnra AC, Tchounga B, Prince-Davi M, Becquet R, Pitche VP.

Sante Publique. 2013 Jul-Aug;25(4):491-8. French.

PMID:
24404731
15.

Surveillance for rotavirus gastroenteritis in children less than 5 years of age in Togo.

Tsolenyanu E, Seheri M, Dagnra A, Djadou E, Tigossou S, Nyaga M, Adjeoda E, Armah G, Mwenda JM, Atakouma Y.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S14-8. doi: 10.1097/INF.0000000000000046.

PMID:
24343607
16.

National surveillance data on the epidemiology of cholera in Togo.

Landoh DE, Gessner BD, Badziklou K, Tamekloe T, Nassoury DI, Dagnra A, Patassi A, Tante O, Bidjada B, Tigossou S, Banla KA.

J Infect Dis. 2013 Nov 1;208 Suppl 1:S115-9. doi: 10.1093/infdis/jit244. Erratum in: J Infect Dis. 2014 May 1;209(9):1494. Essoya, Landoh Dadja [corrected to Landoh, Dadja Essoya]; Kossi, Badziklou [corrected to Badziklou, Kossi]; Tsidi, Tamekloe [corrected to Tamekloe, Tsidi]; Ibrahim, Nassoury Dalandi [corrected to Nassoury, Danlai Ibrahim]; Anoumou, Dagnra [corrected to Dagnra, Anoumou]; Akouda, Patassi [corrected to Patassi, Akouda]; Abiba, Banla Kere [corrected to Banla, Kere Abiba].

PMID:
24101639
17.

Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.

Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LX, Delaporte E, Chaix ML, Peeters M, Ayouba A; ANRS 12186 Study Group.

Clin Infect Dis. 2014 Jan;58(1):99-109. doi: 10.1093/cid/cit627. Epub 2013 Sep 27.

PMID:
24076968
18.

HIV seroprevalence among inmates in Togo.

Ekouevi DK, D'almeida S, Salou M, Kariyiare BG, Coffie PA, Dagnra AC, Tchounga B, Becquet R, Prince-David M, Pitche VP.

Med Mal Infect. 2013 Jul;43(7):279-85. doi: 10.1016/j.medmal.2013.06.002. Epub 2013 Jul 29.

PMID:
23906419
19.

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.

Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW.

J Infect Dis. 2013 Jun 15;207 Suppl 2:S70-7. doi: 10.1093/infdis/jit114.

20.

High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.

Dagnra AY, Vidal N, Mensah A, Patassi A, Aho K, Salou M, Monleau M, Prince-David M, Singo A, Pitche P, Delaporte E, Peeters M.

J Int AIDS Soc. 2011 Jun 10;14:30. doi: 10.1186/1758-2652-14-30.

Supplemental Content

Loading ...
Support Center